Expression of human papillomavirus genotype 52 pseudovirus in HEK-293T cells

• Published in: IOP conference series. Earth and environmental science Vol. 1271; no. 1; pp. 12086 - 12093
• Main Authors: Kusumawati, A, Septisetyani, E P, Triratna, L, Umami, R N, Hertati, A, Mustopa, A Z
• Format: Journal Article
• Language: English
• Published: Bristol IOP Publishing 01.12.2023
• Subjects: Antibodies; Capsid protein; Cervical cancer; co-transfection; Coding; E coli; Fluorescence; Fluorescence microscopy; Genotypes; HEK-293T cells; HPV52; Human papillomavirus; Immunogenicity; L1 protein; Neutralization; Plasmids; Polyethyleneimine; Proteins; pseudovirus; Transfection; Vaccines
• ISSN: 1755-1307; 1755-1315
• DOI: 10.1088/1755-1315/1271/1/012086

Abstract Human papillomavirus (HPV) is the predominant cause of cervical cancer globally. HPV genotype 52 is categorized as a high-risk type and holds the highest prevalence in Indonesia (23.2 %). The HPV pseudovirus can be used to test the immunogenicity of HPV vaccine candidates and evaluate the neutralization efficiency of the antibodies against the virus. The aim of this study was to express the HPV52 L1 and L2 capsid protein into pseudovirion containing the GFP reporter plasmid (pfwB) in HEK-293T cells. HPV52 L1 and L2 coding plasmid (pVITRO52) along with pfwB were amplified in E. coli . The plasmids were extracted and co-transfected using polyethyleneimine (PEI)-based transfection method into the HEK-293T cells. The expression of HPV52 pseudoviruses were confirmed by fluorescence microscopy and western blot method. Co-transfection of HPV52 L1 and L2 coding plasmid (pVITRO52) along with pfWB into the HEK-293T cells was successfully carried out. The co–transfected HEK-293T cells showed fluorescence. The western blot assay using HPV52 L1 protein primary antibody showed a band around ∼55 kDa. In the future, the results of this study will be used to evaluate the immunogenicity and neutralization assay of HPV vaccine candidates.